Funds a Clinical Coordinating Center to lead multi-site clinical trials using innovative designs, focusing on NHLBI’s mission and health outcome disparities.
Gateway Traditional Grant Program supports researchers at institutions worldwide to conduct early-phase cancer treatment trials that center patients and could change the standard of care.
CRI Clinical Innovator supports academic researchers leading early-phase cancer immunotherapy trials to test novel treatments, study response mechanisms, and identify biomarkers to improve patient outcomes.
This grant supports a network to quickly conduct clinical trials on infectious diseases, evaluating treatments and diagnostics for public health needs under NIH and NIAID priorities.
The Joint ECOG-ACRIN Program supports cancer researchers expanding innovative phase II trials into community care settings, with the goal of reducing cancer’s burden and improving adults’ quality of life and survival.